While the major PBMs still dominate the market, their grip is loosening. A recent Pulse of the Purchaser survey found that the percentage of employers contracted with one of the Big 3 dropped from 72% in 2024 to 61% by late 2025, as more organizations shifted toward transparent PBMs.
One possible reason for that shift is growing awareness of the “rebate guarantee myth.” Some PBMs waive a client’s administration fees in exchange for retaining drugmaker rebates… but to protect their profits, those PBMs steer patients toward higher-cost drugs that generate larger rebates. For employers, the math works against them: A $1.00 increase in rebates typically corresponds to a $1.17 increase in total drug costs.
MedBen Rx was built to eliminate pricing games. We ensure you know where every prescription dollar is going and why, without hidden markups or margin manipulation. You pay what the pharmacy pays, and 100% of paid rebates are returned to your plan, where they belong.
Bottom line, it’s your money! Learn how MedBen Rx delivers transparent pricing that works for you by contacting your broker or MedBen Marketing.